Gain of chromosome 1q portends worse prognosis in multiple myeloma despite novel agent-based induction regimens and autologous transplantation

We aimed to identify whether the use of autologous hematopoietic cell transplantation (HCT) impacts outcomes for multiple myeloma patients with gains of chromosome 1q (+1q). We retrospectively identified 95 patients, 21% having +1q. For patients with +1q, the overall response rate to induction was 8...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Leuk Lymphoma
Main Authors: Shah, Gunjan L., Landau, Heather, Londono, Dory, Devlin, Sean M., Kosuri, Satyajit, Lesokhin, Alexander M., Lendvai, Nikoletta, Hassoun, Hani, Chung, David J., Koehne, Guenther, Jhanwar, Suresh C., Landgren, Ola, Levine, Ross, Giralt, Sergio A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5554510/
https://ncbi.nlm.nih.gov/pubmed/28078910
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10428194.2016.1260126
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados